On Thursday, Progressive Corp. (NYSE:PGR)’s shares declined -0.45%, and closed at $26.84, as Progressive Corp., declared the successful completion of the formerly declared attainment of a controlling interest in ARX Holding Corp., the parent corporation of American Planned Insurance Corp., one of the twenty largest homeowners insurance carriers in the United States.
The Progressive Corporation, an insurance holding corporation, provides personal and commercial property-casualty insurance, and other specialty property-casualty insurance and related services primarily in the United States.
Cisco Systems, Inc. (NASDAQ:CSCO)’s shares dropped -0.44%, and settled at $27.13, during the last trading session on Thursday, as on Monday, April 6, 2015, Cisco (CSCO) will host a Tech Talk with UBS Securities to talk about Cisco’s packet-optical convergence strategy. Bill Gartner, Vice President of Optical Systems and Transceivers Group, will give a brief presentation and address questions during the webcast/conference call, at 12:00 pm EDT / 9:00 am PDT.
Cisco Systems, Inc. designs, manufactures, and sells Internet Protocol (IP) based networking products and services related to the communications and information technology industry worldwide.
At the end of Thursday’s trade, Cypress Semiconductor Corporation (NASDAQ:CY)’s shares dipped -0.43%, and closed at $13.86.
Formerly on March 26, Cypress Semiconductor, declared the expansion of its Traveo™ microcontroller (MCU) family with a new series that provides automotive manufacturers with a cost-effective platform to deliver 2-D and 3-D graphics and advanced functionality for dashboards, head-up displays and HVAC systems in compact vehicles. The S6J32BA and S6J32DA series build upon Spansion’s declaration of the Traveo 2-D graphics MCU S6J324C series and the 3-D graphics MCU S6J326C series for midsize cars in October 2014.
The new Cypress Traveo S6J32BA and S6J32DA product family comprises the ARM Cortex-R5 processor, 1MB of internal flash, 1MB of internal video RAM, improved secure hardware extension (eSHE) and the industry-leading HyperBus™ interface. The interface enables seamless connections with HyperBus memories such as HyperFlash™ memory and HyperRAM™ memory. The S6J32BA and S6J32DA series are pin compatible with their predecessors S6J324C and S6J326C, providing customers the flexibility and ease to upgrade without requiring changes to the board layout. The graphics functionality is complemented by an advanced sound system with a 16-bit Audio-DAC and a multi-channel mixer.
Cypress Semiconductor Corporation provides mixed-signal programmable solutions, specialized semiconductor memories, and integrated semiconductor solutions worldwide. The corporations Memory Products division designs and manufactures static random access memory (SRAM) products and nonvolatile RAMs used to store and retrieve data in networking, wireless infrastructure and handsets, computation, consumer, automotive, industrial, and other electronic systems; and general-purpose programmable clocks.
Eli Lilly and Company (NYSE:LLY), ended its Thursday’s trading session with -0.41% loss, and closed at $71.24.
Eli Lilly and Company, will declare its financial results for the first quarter of 2015 on Thursday, April 23, 2015. Lilly will also conduct a conference call on that day with the investment community and media to further detail the corporation’s financial performance.
The conference call will start at 9:00 a.m. EDT. Investors, media, and the general public can access a live webcast of the conference call through a link that will be posted on Lilly’s website at www.lilly.com. A replay will also be accessible on the website following the conference call.
Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates in two segments, Human Pharmaceutical Products and Animal Health products. The corporation offers endocrinology products to treat diabetes; osteoporosis in postmenopausal women and men; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
